Zhen Shang Selected Research

Zhen Shang Research Topics

7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 11/2012
3	Neoplasms (Cancer) 10/2021 - 01/2014
3	Leukemia 12/2015 - 11/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2019
1	Multiple Myeloma 01/2018
1	Neuralgia (Stump Neuralgia) 01/2018
1	Pain (Aches) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Carcinogenesis 01/2017
1	Cardiotoxicity 01/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2014

3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2013 - 12/2012
2	Bortezomib (Velcade)FDA Link 01/2018 - 01/2014
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Circular RNAIBA 10/2021
1	GlucocorticoidsIBA 01/2021
1	Inosine Triphosphate (ITP)IBA 01/2021
1	Decitabine FDA Link 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Trace Elements (Biometals)IBA 01/2019
1	ZincIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	MicroRNAs (MicroRNA)IBA 06/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Transcription Activator-Like Effector NucleasesIBA 12/2015
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2014
1	Protein Isoforms (Isoforms)IBA 12/2012
1	Biological ProductsIBA 11/2012
1	Core Binding Factors (Core-Binding Factor)IBA 11/2012